Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NEK4

RBC: NEK4 · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Ponatinib100.00.53
Defactinib81.90.45
Bosutinib76.20.55
Abemaciclib71.40.56
Gilteritinib54.00.51
Ripretinib51.60.67
Neratinib49.90.60
Brigatinib40.00.51
Crizotinib35.50.58
Repotrectinib29.00.61
Midostaurin27.90.50
Vemurafenib22.60.60
Encorafenib21.80.76
Dabrafenib19.90.63
Pazopanib18.90.67

Known variants

No variants catalogued.
Open in new tab